全文获取类型
收费全文 | 7184篇 |
免费 | 139篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 273篇 |
儿科学 | 287篇 |
妇产科学 | 375篇 |
基础医学 | 392篇 |
口腔科学 | 145篇 |
临床医学 | 393篇 |
内科学 | 1502篇 |
皮肤病学 | 321篇 |
神经病学 | 325篇 |
特种医学 | 511篇 |
外科学 | 1981篇 |
综合类 | 27篇 |
预防医学 | 231篇 |
眼科学 | 254篇 |
药学 | 36篇 |
中国医学 | 2篇 |
肿瘤学 | 278篇 |
出版年
2023年 | 11篇 |
2021年 | 14篇 |
2019年 | 10篇 |
2018年 | 28篇 |
2017年 | 25篇 |
2016年 | 29篇 |
2015年 | 506篇 |
2014年 | 573篇 |
2013年 | 575篇 |
2012年 | 593篇 |
2011年 | 530篇 |
2010年 | 606篇 |
2009年 | 564篇 |
2008年 | 596篇 |
2007年 | 520篇 |
2006年 | 484篇 |
2005年 | 416篇 |
2004年 | 285篇 |
2003年 | 74篇 |
2002年 | 30篇 |
2001年 | 42篇 |
2000年 | 34篇 |
1999年 | 52篇 |
1998年 | 32篇 |
1997年 | 56篇 |
1996年 | 44篇 |
1995年 | 31篇 |
1994年 | 29篇 |
1993年 | 29篇 |
1992年 | 26篇 |
1991年 | 27篇 |
1990年 | 23篇 |
1989年 | 24篇 |
1988年 | 28篇 |
1987年 | 22篇 |
1986年 | 21篇 |
1985年 | 17篇 |
1984年 | 12篇 |
1983年 | 38篇 |
1982年 | 31篇 |
1981年 | 38篇 |
1980年 | 28篇 |
1979年 | 29篇 |
1977年 | 14篇 |
1976年 | 19篇 |
1975年 | 12篇 |
1974年 | 9篇 |
1973年 | 9篇 |
1972年 | 15篇 |
1971年 | 9篇 |
排序方式: 共有7333条查询结果,搜索用时 29 毫秒
81.
MJ Stevens PD Stricker J Saalfeld PC Brenner R Kooner GFA O'Neill PJ Duval RS Jagavkar P Cross J Martland 《Journal of Medical Imaging and Radiation Oncology》2003,47(2):152-160
Combination high dose rate brachytherapy (HDRB) and external beam radiation therapy is technically and clinically feasible as definitive treatment for localized prostate cancer. We report the first large Australian experience using this technique of radiation dose escalation in 82 patients with intermediate‐ and high‐risk disease. With a median follow up of 3 years (156 weeks), complications were low and overall prostate‐specific antigen progression‐free survival was 91% using the American Society for Therapeutic Radiology and Oncology consensus definition. The delivery of hypofractionated radiation through the HDRB component shortens overall treatment time and is both biologically and logistically advantageous. As a radiation boost strategy, HDRB is easy to learn and could be introduced into most facilities with brachytherapy capability. 相似文献
82.
Frequency of pancreatitis after endoscopic retrograde cholangiopancreatography with iopromid or iotrolan: a randomized trial 总被引:1,自引:0,他引:1
Blood isotone contrast media is considered to be less toxic to vascular and pancreatic duct endothelium than high-osmolar
contrast media. In this study we assessed the impact of a low-osmolar contrast agent compared with a blood isotone product
on pancreatic damage induced by endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic retrograde sphincterotomy
(EST). In a prospective trial 42 consecutive ERCP/EST patients were randomized to receive either iopromid, a low-osmolar non-ionic
contrast agent (770 mosmol/kg H2O), or iotrolan, a blood-isotone non-ionic product (320 mosmol/kg H2O). The endoscopies were performed by two experienced endoscopists. Forty patients were included in the study. Blood samples
were collected before and 40 min, 2, 4, 6 and 24 h after the endoscopic procedure. Samples were analysed for pancreatic serum
enzymes, acute-phase proteins and blood counts. A clinical pain score was investigated. Post-ERCP pancreatitis was diagnosed
in 2 patients in the iopromid group and in 5 patients in the iotrolan group. There was no significant difference between groups
in the time course of pancreatic serum enzymes, acute-phase proteins or in the pain score. Due to the small number of patients
in this study, only stronger differences caused by the two contrast media could have led to statistically significant results.
We did not observe statistically significant differences in comparing iotrolan and iopromid concerning ERCP/EST-induced pancreatic
damage.
Received: 26 February 1999; Revised: 14 May 1999; Accepted: 9 June 1999 相似文献
83.
Tyrosinemia type I is an autosomal recessive inherited defect of tyrosine metabolism. The underlying cause is a defect of fumarylacetoacetate hydrolase. The disease affects the liver (acute liver failure, liver cirrhosis, hepatocellular cancer), the kidney (tubulopathy with hypophosphatemic rickets), and the peripheral nervous system (paresthesia, vegetative symptoms, progressive paralysis). Beside the hypertyrosinemia the diagnosis can be made on the basis of urinary excretion of a pathological metabolite of the tyrosine metabolism (succinylacetone). Therapeutic options are a regulated phenylalanine/tyrosine diet, a very effective drug therapy (NTBC) that has been available for several years, and in cases of acute liver failure or end-stage liver cirrhosis a liver transplantation. 相似文献
84.
Ohne Zusammenfassung 相似文献
85.
PD Dr. F. Bahlmann 《Der Gyn?kologe》2004,37(8):725-736
In monochorionic twin pregnancies, the risk of developing a twin to twin transfusion syndrome is between 15 and 20%. Using high-resolution ultrasound machines, sonographic images demonstrate the detailed features of placental development. The lambda sign was established for the diagnosis of dichorionic placenta and the T sign for monochorionic placenta at the end of the first trimester. Other sonographic findings of the twin to twin transfusion syndrome are monochorionicity, same sex, polyhydramnios, permanently filled bladder in the recipient, and oligo/anhydramnios of the donor with a slightly filled or empty bladder. Fetoscopic laser treatment has become an accepted procedure to coagulate the placental anastomoses. This development is supported by actual studies about psycho- and neuromotoric development in early childhood, which shows a lower rate of disabled children in the group receiving laser therapy in comparison to the group undergoing amnioreduction. Twin pregnancies complicated by twin to twin transfusion syndrome should be treated in specialized prenatal centers. 相似文献
86.
PD Dr. T. Moser N. Strenzke A. Meyer A. Lesinski-Schiedat T. Lenarz D. Beutner A. Foerst R. Lang-Roth H. von Wedel M. Walger M. Gross A. Keilmann A. Limberger T. Steffens J. Strutz 《HNO》2006,54(11):833-841
Pathological auditory brainstem responses (lack of responses, elevated thresholds and perturbed waveforms) in combination with present otoacoustic emissions are typical audiometric findings in patients with a hearing impairment that particularly affects speech comprehension or complete deafness. This heterogenous group of disorders first described as “auditory neuropathy” includes dysfunction of peripheral synaptic coding of sound by inner hair cells (synaptopathy) and/or of the generation and propagation of action potentials in the auditory nerve (neuropathy). This joint statement provides prevailing background information as well as recommendations on diagnosis and treatment. The statement focuses on the handling in the german language area but also refers to current international statements. 相似文献
87.
Minimally invasive diagnostic procedures for the breast under mammography, ultrasound, and magnetic resonance guidance have led to a higher specificity of imaging techniques and a decrease in open biopsy of the breast. The percutaneous approach is more cost and time effective and reduces morbidity compared with open biopsy. The “Step-3-guideline for early breast cancer detection in Germany” represents the first national guidelines for a nationwide, quality assured, early breast cancer detection program, including recommendations for minimally invasive breast diagnostics. Indications for ultrasound guided vacuum biopsy of the breast are summarized in the “Consensus on the use and technique of vacuum-assisted sonographic breast biopsy” by the Study Group on Minimally Invasive Breast Interventions (AG MiMi) of the German Society of Senology (DGS). 相似文献
88.
Huber TS Carlton LM O'Hern DG Hardt NS Keith Ozaki C Flynn TC Seeger JM 《Annals of surgery》2000,231(6):860-868
OBJECTIVE: To analyze the financial impact of three complex vascular surgical procedures to both an academic hospital and a department of surgery and to examine the potential impact of decreased reimbursements. SUMMARY BACKGROUND DATA: The cost of providing tertiary care has been implicated as one potential cause of the financial difficulties affecting academic medical centers. METHODS: Patients undergoing revascularization for chronic mesenteric ischemia, elective thoracoabdominal aortic aneurysm repair, and treatment of infected aortic grafts at the University of Florida were compared with those undergoing elective infrarenal aortic reconstruction and carotid endarterectomy. Hospital costs and profit summaries were obtained from the Clinical Resource Management Office. Departmental costs and profit summary were estimated based on the procedural relative value units (RVUs), the average clinical cost per RVU ($33.12), surgeon charges, and the collection rate for the vascular surgery division (30.2%) obtained from the Faculty Group Practice. Surgeon work effort was analyzed using the procedural work RVUs and the estimated total care time. The analyses were performed for all payors and the subset of Medicare patients, and the potential impact of a 15% reduction in hospital and physician reimbursement was analyzed. RESULTS: Net hospital income was positive for all but one of the tertiary care procedures, but net losses were sustained by the hospital for the mesenteric ischemia and infected aortic graft groups among the Medicare patients. In contrast, the estimated reimbursement to the department of surgery for all payors was insufficient to offset the clinical cost of providing the RVUs for all procedures, and the estimated losses were greater for the Medicare patients alone. The surgeon work effort was dramatically higher for the tertiary care procedures, whereas the reimbursement per work effort was lower. A 15% reduction in reimbursement would result in an estimated net loss to the hospital for each of the tertiary care procedures and would exacerbate the estimated losses to the department. CONCLUSIONS: Caring for complex surgical problems is currently profitable to an academic hospital but is associated with marginal losses for a department of surgery. Economic forces resulting from further decreases in hospital and physician reimbursement may limit access to academic medical centers and surgeons for patients with complex surgical problems and may compromise the overall academic mission. 相似文献
89.
Zusammenfassung Beim differenzierten Schilddrüsenkarzinom besteht bei nicht Organkapsel überschreitendem Tumorwachstum und adäquater Operation keine Indikation zur postoperativen Bestrahlung. Bei Patienten mit Organkapsel überschreitendem Wachstum wird nach vollständiger Resektion der Nutzen einer zusätzlichen perkutanen Radiotherapie kontrovers diskutiert. Die MSDS-Studie (Multizenterstudie Differenziertes Schilddrüsenkarzinom), die eine Randomisierung genau zu dieser Fragestellung durchführte, musste aufgrund der mangelnden Rekrutierung vorzeitig beendet werden. Beim anaplastischen Schilddrüsenkarzinom wird die vollständige Resektion angestrebt. Die postoperative Bestrahlung ist dann obligat. Bei Therapieprotokollen mit zusätzlicher Adriamycingabe konnten erhöhte lokale Kontroll- und Überlebensraten beobachtet werden. Bei medullärem Schilddrüsenkarzinom und inkompletter Tumorresektion geht eine additive Radiotherapie mit einer verbesserten lokalen Kontrolle einher. Bei nicht Radiojod speichernden Metastasen des Schilddrüsenkarzinoms wird die Radiotherapie im Bereich des Knochens bei Schmerzen, Frakturgefahr oder Myelonkompression eingesetzt. 相似文献
90.
Zusammenfassung Multimodale Therapiestrategien, die Chirurgie, Strahlen- und Chemotherapie kombinieren, haben die Behandlungsergebnisse bei Tumoren der Lunge und der Kopf-Hals Region verbessert. Die Ergänzung des Therapiespektrums um weitere Ansätze, die sich in der Wirkungsweise und möglichst durch reduzierte Toxizität von den konventionellen unterscheiden, erscheint jedoch zur Erzielung weiterer Fortschritte notwendig. Eine neue Generation immunologischer passiver (antikörperbasierter) und auch aktiver (Vakzinierungs-) Strategien erscheint aussichtsreich und befindet sich gegenwärtig in der klinischen Prüfung. Die Untersuchung der optimalen zeitlichen Sequenz in Kombination mit den konventionellen Therapieverfahren und die Individualisierung der Therapie auf Basis genomischer/proteomischer Daten muss die klinische Integration begleiten. 相似文献